| Schedule of Business Combinations |
Details of business combinations that
occurred for the six months ended June 30, 2026 and 2025 are as follows:
| | | | | For the six months ended
June 30, 2026 | | | | | | | | | Ownership | | | Total | | | Acquiree | | Main business | | Acquisition date | | (%) | | | consideration | | | Woori-IO | | Blood glucose monitor, etc | | January 1, 2026 | | | 100.0 | % | | | 10,453,116 | |
|
| Schedule of Identifiable Assets and Liabilities and Goodwill |
Details
of identifiable assets and liabilities and goodwill, which are recognized as the result of the acquisition of Woori-IO completed during
the six months ended June 30, 2026 are set forth in the table below.
| | |
Woori-IO | |
| Fair value of total identifiable assets: | |
| |
| Current assets: | |
| |
| Cash and cash equivalents | |
| 10,982 | |
| Trade and other receivables | |
| 56,497 | |
| Inventories | |
| 224,406 | |
| Other assets | |
| 64,810 | |
| Non-current assets: | |
| | |
| Equipment and vehicles | |
| 1,829 | |
| Right-of-use assets | |
| 10,020 | |
| Intangible assets | |
| 25,604 | |
| | |
| 394,148 | |
| Fair value of total identifiable liabilities: | |
| | |
| Current liabilities: | |
| | |
| Trade and other payables | |
| 371,951 | |
| Lease liabilities | |
| 506,594 | |
| Current other liabilities | |
| 14,852 | |
| Non-current liabilities: | |
| | |
| Severance payment | |
| 65,986 | |
| Deferred tax liabilities | |
| 508,733 | |
| | |
| 1,468,116 | |
| Fair value of identifiable net assets | |
| (1,073,968 | ) |
| Patent | |
| 6,566,615 | |
| Goodwill | |
| 6,405,124 | |
| Deferred tax liabilities | |
| (1,444,655 | ) |
| Purchase consideration transferred (*) | |
| 10,453,116 | |
(*1) OSRK ordinary shares issued for
purchase consideration of $10,453,116 is 84,338 shares at $124 per share. The number of OSRK ordinary shares to be issued was determined
based on negotiation with former owners of Woori-IO.
|